Delivery Order SPE2DB24D9223-SPE2DB24FKDXV

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order worth $5,965.88 for the supply of Rituxan, a 500 mg/50 ml vial medication, with a period of performance through March 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,227.00 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, with a period of performance ending on November 18, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $63,838.20 firm fixed-price delivery order is for the supply of Rituxan 500 mg/50 ml vials, which are used to treat various medical conditions. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,187.29 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. This single-award...
This federal contract award, valued at $16,466.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product Rituxan Hycela (1,400 mg-23,400 11.7 ml) and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger five-year, $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,879.94 firm fixed-price delivery order contract is for the provision of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The award is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,931.76 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, and has an ultimate completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
The federal contract award SPE2DB20D9331|SPE2DB22FL0W3 was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,196.58 firm fixed-price delivery order is for the supply of Rituxan 500 mg/50 ml vials. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which provides a wide range of pharmaceutical products and medical...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB24FKDXV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a Firm Fixed Price Delivery Order valued at $41,649.97, is for the supply of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military health facilities worldwide.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the diverse medical requirements of the Department of Defense (DoD) healthcare system. As a prime vendor for the DLA, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, biologics, and medical supplies, to support military personnel and their dependents across various DoD facilities.

Generated 10/23/24, 9:37 AM